The national myelodysplastic syndromes (MDS) natural history study- central laboratory and biorepository

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN268201400003I
Awardee
Awarding agency
Task orders
3 $15,199,796 obligated

Award facts

Combined order value
$15,199,796 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 98% used
$15,459,224.82
Maximum order
$15,459,224.82
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services, to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The contract, valued at up to $15,459,224.82, is for the National Myelodysplastic Syndromes (MDS) Natural History Study, which involves the operation of a central laboratory and biorepository to support medical research on MDS, a type of blood cancer.

The contract has been executed through multiple task orders, with the largest being a $12,953,435.66 order for the continuation of the study from September 2016 through December 2025. Other task orders provide additional funding for the central laboratory and biorepository services. As the prime contractor, the H. Lee Moffitt Cancer Center and Research Institute, a non-profit hospital and National Cancer Institute-designated comprehensive cancer center, is responsible for providing specialized medical research, sample collection, and diagnostic support services to advance the NHLBI's understanding and treatment of MDS.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 · IPP - the national myelodysplastic syndromes (MDS) natural history study- central laboratory and biorepository $0
Other Administrative Action P00006 $0
Additional Work (new agreement, FAR part 6 applies) P00005 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN268201400003I?

HHSN268201400003I was awarded to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 4, 2014.

How much is contract HHSN268201400003I worth?

Orders under HHSN268201400003I have obligated $15,199,796. HHSN268201400003I's own ceiling is $15,459,225. A single order can be worth up to $15,459,225.

How many orders have been placed under contract HHSN268201400003I?

3 orders have been placed under HHSN268201400003I, the latest on August 30, 2016.

Who can order from contract HHSN268201400003I?

HHSN268201400003I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN268201400003I competed?

The extent of competition for HHSN268201400003I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV